INS and type 2 diabetes mellitus: (65) found that glucolipotoxicity impaired insulin secretion and changed the expression of 1,855 genes, including 35 of 264 T2DM candidate genes identified by genome-wide association studies such as TCF7L2, BCL11A, and CDKN2B, and the genes of downregulated metabolic pathways were enriched.